combination of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) to improve angiogenic gene therapy.

combination of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) to improve angiogenic gene therapy. Angiogenesis. 2003; 6(3):185-92.

View in: PubMed

subject areas

Animals
Cell Proliferation
Cells, Cultured
COS Cells
Culture Media, Conditioned
Drug Therapy, Combination
Endothelium, Vascular
Genetic Therapy
Genetic Vectors
Humans
Neovascularization, Physiologic
Thymidine Phosphorylase
Thymine
Transfection
Umbilical Veins
Vascular Endothelial Growth Factor A

authors with profiles

Mirjam Boelens